Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: Duration of carriage and risk factors for persistent carriage

Clinical Microbiology and Infection

Volumn 19, Issue 4, 2013, Pages

  Feldman, N ^a   Adler, A ^b   Molshatzki, N ^a   Navon Venezia, S ^b   Khabra, E ^b   Cohen, D ^a   Carmeli, Y ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Carbapenem resistance; Charlson's score; Colonic carriage; Enterobacteriaceae; KPC producing Klebsiella pneumoniae; Long term care facilities

Indexed keywords

CARBAPENEMASE;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; BACTERIUM CULTURE; BACTERIUM ISOLATION; BARTHEL INDEX; CATHETER; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEALTH CARE FACILITY; HOSPITAL DISCHARGE; HUMAN; INTESTINE FLORA; KLEBSIELLA PNEUMONIAE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RESIDENTIAL CARE; RISK FACTOR; SURVIVAL;

ENTEROBACTERIACEAE; KLEBSIELLA PNEUMONIAE;

EID: 84875536106     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12099     Document Type: Article

References (29)

1. Bradford PA, Bratu S, Urban C et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing' KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin Infect Dis 2004; 39: 55-60.
2. Yigit H, Queenan AM, Anderson GJ et al. Novel carbapenem-hydrolyzing β -lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45: 1151-1161.
3. Woodford N, Tierno PM, Young K et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem- hydrolyzing class A β-lactamase, KPC-3, in a New York medical center. Antimicrob Agents Chemother 2004; 48: 4793-4799.
4. Bush K, Fisher JF. Epidemiological expansion, structural studies, and clinical challenges of new beta-lactamases from gram-negative bacteria. Ann Rev Microbiol 2011; 65: 455-478.
5. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009; 9: 228-236.
6. Won SY, Munoz-Price LS, Lolans K, Hota B, Weinstein RA, Hayden MK. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2011; 53: 532-540.
7. KPC-2 by the spread of Klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae species in Brazil. Antimicrob Agents Chemother 2011; 55: 3579-3583.
8. Navon-Venezia S, Leavitt A, Schwaber MJ et al. First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob Agents Chemother 2009; 53: 818-820.
9. KPC-negative sequence-type 258 Klebsiella pneumoniae clone. J Clin Microbiol 2012; 50: 3180-3185.
10. Schechner V, Kotlovsky T, Kazma M et al. Asymptomatic rectal carriage of bla(KPC) producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? Clin Microbiol Infect 2012 [Epub ahead of print]. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22563800 (last accessed on 1 November 2012).
11. Borer A, Saidel-Odes L, Eskira S et al. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K. pneumoniae. Am J Infect Control 2012; 40: 421-425.
12. Bilavsky E, Schwaber MJ, Carmeli Y. How to stem the tide of carbapenemase-producing Enterobacteriaceae?: proactive vs. reactive strategies. Curr Opinion Infect Dis 2010; 23: 327-331.
13. Wiener-Well Y, Rudensky B, Yinnon AM et al. Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak. J Hosp Infect 2010; 74: 344-349.
14. Calfee D, Jenkins SG. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol 2008; 29: 966-968.
15. Lledo W, Hernandez M, Lopez E et al. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR 2009; 58: 256-260.
16. Ben-David D, Maor Y, Keller N et al. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 2010; 31: 620-626.
17. Schwaber MJ, Lev B, Israeli A et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011; 52: 848-855.
18. Schechner V, Kotlovsky T, Tarabeia J et al. Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter. Infect Control Hosp Epidemiol 2011; 32: 497-503.
19. Adler A, Navon-Venezia S, Moran-Gilad J, Marcos E, Schwartz D, Carmeli Y. Laboratory and clinical evaluation of screening agar plates for detection of carbapenem-resistant enterobacteriaceae from surveillance rectal swabs. J Clin Microbiol 2011; 49: 2239-2242.
20. Shah S, Vanclay F, Cooper B. Improving the sensitivity of the Barthel Index for stroke rehabilitation. J Clin Epidemiol 1989; 42: 703-709.
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373-383.
22. Schechner V, Straus-Robinson K, Schwartz D et al. Evaluation of PCR-based testing for surveillance of KPC-producing carbapenem-resistant members of the Enterobacteriaceae family. J Clin Microbiol 2009; 47: 3261-3265.
23. Israeli National Center of Infection Control. Guidelines for active surveillance for CRE carriage in general hospitals. Tel-Aviv: Israeli National Center of Infection Control, 2008: 1-2.
24. Ben-David D, Masarwa S, Navon-Venezia S et al. Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel. Infect Control Hosp Epidemiol 2011; 32: 845-853.
25. Borer A, Eskira S, Nativ R et al. A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in Southern Israel. Infect Control Hosp Epidemiol 2011; 32: 1158-1165.
26. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008; 52: 1028-1033.
27. Apisarnthanarak A, Bailey TC, Fraser VJ. Duration of stool colonization in patients infected with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 2008; 46: 1322-1323.
28. Goren MG, Carmeli Y, Schwaber MJ, Chmelnitsky I, Schechner V, Navon-Venezia S. Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient. Emerg Infect Dis 2010; 16: 1014-1017.
29. Mathers AJ, Cox HL, Kitchel B et al. Molecular dissection of an outbreak of carbapenem-resistant Enterobacteriaceae reveals intergenus KPC carbapenemase transmission through a promiscuous plasmid. MBio 2011; 2: e00204-e00211.